subject: PUBCHEM.COMPOUND:64730


subject: PUBCHEM.COMPOUND:64730

subject_name: acid citrate dextrose

object_name: ovarian carcinoma

tested_intervention: unsure


subject: CHEBI:195314

object_name: fallopian tube carcinoma


subject: CHEBI:195314

object_name: fallopian tube cancer


subject: CHEBI:195314

object_name: primary peritoneal carcinoma


subject: CHEBI:195314

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:195314

object_name: peritoneal carcinoma


subject: CHEBI:195314

object_name: ovarian cancer


subject: CHEBI:195314

object_name: ovarian neoplasm


subject: CHEBI:195314


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Moderate albuminuria

tested_intervention: yes


subject: UNII:0E3D72URPD

object_name: Hay fever


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Wheezing


subject: UNII:420K487FSG

object_name: Wheezing, CTCAE


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: systemic inflammatory response syndrome


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: coronary artery disorder


subject: CHEBI:6888

object_name: coronary atherosclerosis


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: UMLS:C0445115


subject: UMLS:C4528719

object_name: female reproductive organ cancer


subject: CHEBI:8863

subject_name: Riluzole

object_name: Alzheimer disease


subject: UMLS:C1831860

subject_name: Beneo Synergy 1

object_name: Pediatric Obesity


subject: CHEMBL.COMPOUND:CHEMBL1743003

subject_name: CONATUMUMAB

object_name: metastatic colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: rectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: neoplasm


subject: UMLS:C2346822

subject_name: conatumumab


subject: CHEBI:9434

subject_name: Telmisartan

object_name: coronary microvascular disorder


subject: DRUGBANK:DB18996

subject_name: Povetacicept

object_name: cold agglutinin disease


subject: DRUGBANK:DB18996

object_name: autoimmune hemolytic anemia, cold type


subject: DRUGBANK:DB18996

object_name: autoimmune thrombocytopenia


subject: DRUGBANK:DB18996

object_name: thrombocytopenia due to immune destruction


subject: DRUGBANK:DB18996

object_name: autoimmune thrombocytopenic purpura


subject: DRUGBANK:DB18996

object_name: autoimmune hemolytic anemia, warm type


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Postoperative Complications


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: diabetic kidney disease


subject: CHEBI:131391


subject: CHEBI:49956

subject_name: Xenon

object_name: Hemodynamic stability


subject: UMLS:C0030956

subject_name: Peptides

object_name: Solid Neoplasm


subject: CHEBI:64312

subject_name: Memantine

object_name: Atrial premature beats, contractions, or systoles


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Intraoperative blood loss


subject: CHEBI:8884

object_name: Intraoperative Hemorrhage


subject: CHEBI:8884

object_name: Complication of anesthesia


subject: CHEBI:8884

object_name: Postoperative Hemorrhage


subject: CHEBI:17754

subject_name: Glycerin

object_name: trigeminal neuralgia


subject: CHEBI:17754

object_name: headache disorder


subject: UMLS:C1872504

object_name: chronic obstructive pulmonary disease


subject: MESH:C000709231

object_name: breast neoplasm


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated

object_name: influenza


subject: UMLS:C5241183

subject_name: Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)


subject: CHEBI:57694

object_name: Fanconi anemia


subject: CHEBI:57694

object_name: Fanconi anemia complementation group A


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:50733


subject: UNII:XN7HA74WB0

object_name: Premature (early) ejaculation


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Metastases to perineum


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C4053669

object_name: prostate carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: interstitial lung disease 1


subject: UNII:52CMI0WC3Y

object_name: interstitial lung disease 2


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL4297752

subject_name: FERRIC PYROPHOSPHATE

object_name: Helicobacter pylori infection


subject: CHEBI:132767

subject_name: Ferric pyrophosphate


subject: CHEBI:31607

subject_name: Ferrous fumarate


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Muscle Invasive Bladder Carcinoma


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: bladder tumor


subject: UNII:OX5LRQ5H6K

object_name: urinary bladder carcinoma


subject: UNII:OX5LRQ5H6K

object_name: urinary bladder cancer


subject: UNII:OX5LRQ5H6K

object_name: childhood bladder carcinoma


subject: UNII:OX5LRQ5H6K


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: CHEBI:6456

subject_name: Lidocaine

object_name: musculoskeletal system disorder


subject: CHEBI:6456

object_name: Leg Injuries


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: Decreased liver function


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: DS Stage III Plasma Cell Myeloma


subject: UNII:1351PE5UGS

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:1351PE5UGS

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:17347

subject_name: Testosterone

object_name: Urinary incontinence


subject: CHEBI:17347

object_name: Urinary Incontinence, CTCAE 5.0


subject: UMLS:C0018284

subject_name: Growth Factor

object_name: Premature Labor


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Postoperative Vasoplegic Syndrome


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:168426

subject_name: ethyl citrate

object_name: Childhood Breast Carcinoma


subject: CHEBI:168426

object_name: breast carcinoma


subject: CHEBI:168426

object_name: breast cancer


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:27732


subject: PR:000005402

subject_name: chromatin assembly factor 1 subunit A


subject: PR:000005402


subject: PR:000005402


subject: CHEBI:74824

subject_name: Thr-Ala


subject: CHEBI:74824


subject: CHEBI:74824


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PUBCHEM.COMPOUND:4532223


subject: PUBCHEM.COMPOUND:4532223


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000006886


subject: PR:000006886


subject: PR:000016550


subject: PR:000016550


subject: PR:000016550


subject: UMLS:C0001369

subject_name: Acyl Carrier Protein


subject: UMLS:C0001369


subject: UMLS:C0001369


subject: CHEBI:3757

subject_name: Clonidine

object_name: Lumbar and other intervertebral disc disorders with radiculopathy


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: MELAS syndrome


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: ankylosing spondylitis


subject: CHEBI:85990

subject_name: Panobinostat

object_name: neuroendocrine neoplasm


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: CHEBI:136519

subject_name: n-butyl isocyanate

object_name: Weight Change


subject: CHEBI:136519

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:136519

object_name: metabolic syndrome X


subject: CHEBI:136519

object_name: Becker muscular dystrophy


subject: CHEBI:136519

object_name: Borrelia miyamotoi disease


subject: CHEBI:136519

object_name: vitelliform macular dystrophy 2


subject: CHEBI:136519

object_name: Bone Mineral Density


subject: CHEBI:136519

object_name: Minority Health


subject: CHEBI:136519

object_name: Fasting


subject: CHEBI:136519

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:136519

object_name: obesity


subject: CHEBI:136519

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:21130

subject_name: imidazole mustard


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: PUBCHEM.COMPOUND:21130


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:31536


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:60481


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: PR:000008953


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: Advanced Melanoma


subject: DRUGBANK:DB17468

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB17468

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C2698691

subject_name: Imprime PGG


subject: UMLS:C2698691


subject: UMLS:C2698691


subject: CHEBI:16349

subject_name: Citrulline

object_name: MELAS syndrome


subject: PR:000009060

subject_name: insulin-like peptide INSL5

object_name: HIV infection


subject: PR:000013980

subject_name: Rho-related GTP-binding protein RhoF


subject: PR:000023845

subject_name: DNA-directed RNA polymerase subunit beta


subject: UniProtKB:P0A8V2

subject_name: RPOB_ECOLI DNA-directed RNA polymerase subunit beta (sprot)


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation


subject: PUBCHEM.COMPOUND:16211421

subject_name: TALC

object_name: non-small cell lung carcinoma


subject: UMLS:C1963644

subject_name: Talc dusting powder


subject: PUBCHEM.COMPOUND:129631692

subject_name: Hexal Hexal

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:129631692

object_name: lymphoma


subject: PUBCHEM.COMPOUND:129631692

object_name: pediatric lymphoma


subject: MESH:C000625933

object_name: hypertension


subject: MESH:C000625933

object_name: Hypertension, CTCAE


subject: MESH:C000625933

object_name: Isolated systolic hypertension


subject: CHEBI:67357

subject_name: Dolastatin 10

object_name: leukemia


subject: CHEBI:67357

object_name: childhood leukemia


subject: CHEBI:67357

object_name: Myelodysplasia


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: PUBCHEM.COMPOUND:71300626

subject_name: Octenisept

object_name: decubitus ulcer


subject: UMLS:C2607383


subject: CHEBI:135826

subject_name: Octenidine


subject: CHEBI:16112

subject_name: Chlorogenate

object_name: type 2 diabetes mellitus


subject: CHEBI:16112

object_name: Chronic uremia


subject: MESH:D053379

subject_name: Chromogranin A


subject: MESH:D053379


subject: CHEBI:75929

object_name: pervasive developmental disorder


subject: CHEBI:75929

object_name: Asperger syndrome


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: paranasal sinus carcinoma


subject: GTOPDB:9758

object_name: paranasal sinus cancer


subject: GTOPDB:9758

object_name: nasal cavity carcinoma


subject: GTOPDB:9758

object_name: nasal cavity cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:90620

subject_name: Vatalanib

object_name: plasma cell myeloma


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C1524078


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: Unresectable Colorectal Carcinoma


subject: UMLS:C4287690

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:LXE89WJ787

object_name: gingivitis


subject: UMLS:C5666956

subject_name: KDM4 Inhibitor TACH101

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5666956

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666956

object_name: Adult Solid Neoplasm


subject: UMLS:C5666956

object_name: Solid Neoplasm


subject: UMLS:C5666956

object_name: Advanced cancer


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Heart failure with normal ejection fraction


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Corneal Injury


subject: UMLS:C0086466

subject_name: Injectables

object_name: heroin dependence


subject: UMLS:C0086466

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:544190

object_name: thrombocytopenia


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UMLS:C3493499

object_name: nicotine dependence


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: Cirrhosis


subject: UMLS:C3714648

object_name: liver cirrhosis


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: CHEBI:66903

subject_name: Vismodegib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:66903

object_name: acute myeloid leukemia


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: pulmonary embolism


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Adult Subependymal Giant Cell Astrocytoma


subject: CHEBI:114785

object_name: Adult Pineal Gland Astrocytoma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Adult Pilocytic Astrocytoma


subject: MESH:C532829

subject_name: fuzheng huayu

object_name: chronic hepatitis C virus infection


subject: UMLS:C3896805

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4733446


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: asthma


subject: UMLS:C2348252

subject_name: Diclofenac Sodium Gel

object_name: actinic keratosis


subject: UMLS:C4305825

object_name: Corneal graft rejection


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: septic shock


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UNII:0NIZ8H6OL8

subject_name: Tetrahydrouridine

object_name: carcinoma of esophagus


subject: UNII:0NIZ8H6OL8

object_name: malignant pleural mesothelioma


subject: CHEBI:36946

subject_name: thiourea

object_name: non-small cell lung carcinoma


subject: CHEBI:36946

object_name: lung cancer


subject: CHEBI:36946

object_name: lung carcinoma


subject: CHEBI:36946


subject: CHEBI:36946


subject: UNII:T5B2GI8F84

subject_name: Setrobuvir


subject: CHEBI:50629

subject_name: cyclooxygenase 2 inhibitor

object_name: female reproductive system disorder


subject: UMLS:C1705207

subject_name: Endostar

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1705207

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:6801

subject_name: Metformin

object_name: hypertriglyceridemia


subject: CHEBI:6801

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: intermittent vascular claudication


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: Erythrodermic psoriasis


subject: UNII:BTY153760O

object_name: psoriasis 14, pustular


subject: UNII:BTY153760O

object_name: generalized pustular psoriasis


subject: CHEBI:40133

subject_name: (R)-Rolipram

object_name: multiple sclerosis


subject: CHEBI:104872

subject_name: Rolipram


subject: UMLS:C5565157

object_name: asthma


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: respiratory failure


subject: CHEBI:55438

object_name: Respiratory Failure, CTCAE


subject: CHEBI:55438

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: PR:000036013

subject_name: angiotensin 1-7

object_name: Coronavinae infectious disease


subject: PR:000036013


subject: PR:000036013


subject: PR:000036013


subject: PR:000036013


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Heberden node


subject: CHEBI:39585

object_name: osteoarthritis, hand


subject: DRUGBANK:DB14311

subject_name: Shea butter


subject: DRUGBANK:DB14311


subject: DRUGBANK:DB14311

object_name: red-green color blindness


subject: DRUGBANK:DB14311

object_name: Deuteranomaly


subject: CHEBI:5959

subject_name: Irbesartan

object_name: Moderate albuminuria


subject: DRUGBANK:DB17411

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:31159

subject_name: Aceclofenac

object_name: Irreversible pulpitis


subject: UMLS:C0054952

subject_name: CD33 antigen

object_name: Neoplasm, Residual


subject: UMLS:C0054952

object_name: adult acute myeloid leukemia


subject: PR:000001892

subject_name: CD33 molecule


subject: PR:000001892


subject: UMLS:C3827169

object_name: Chondrosarcoma, grade 2


subject: UMLS:C3827169

object_name: Chondrosarcoma, grade 3


subject: UMLS:C3827169

object_name: IDH1 gene mutation


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Pseudomonas infection


subject: CHEBI:90936

subject_name: Alectinib

object_name: metastatic colorectal cancer


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:64310

subject_name: Crizotinib


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib


subject: UNII:PF9462I9HX

subject_name: Larotrectinib


subject: CHEBI:85990

subject_name: Panobinostat


subject: GTOPDB:8313

subject_name: talazoparib


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Hodgkin Disease


subject: CHEBI:91450

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:91450

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:91450

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:91450

object_name: anaplastic large cell lymphoma


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273


subject: PUBCHEM.COMPOUND:66660570

subject_name: Evogliptin

object_name: congenital bilateral aplasia of vas deferens from CFTR mutation


subject: PUBCHEM.COMPOUND:66660570

object_name: congenital bilateral absence of vas deferens


subject: CHEBI:3757

subject_name: Clonidine

object_name: withdrawal; therapeutic substance


subject: CHEBI:36796

subject_name: duloxetine

object_name: cancer pain


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: chronic idiopathic urticaria


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: pancreatic neoplasm


subject: UMLS:C2346821

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2346821

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: Diabetes


subject: PUBCHEM.COMPOUND:11227182

object_name: diabetes mellitus


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: precancerous condition


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Neoplasm Recurrence, Local


subject: CHEBI:41774

object_name: Atypical hyperplasia


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: Injury of gastrointestinal tract


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: GTOPDB:9310

subject_name: lirilumab

object_name: head and neck squamous cell carcinoma


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: CHEBI:8888

subject_name: Ropinirole

object_name: sexual disorder


subject: CHEBI:8888

object_name: physiological sexual disorder


subject: UMLS:C1520059

subject_name: Vitamin D Analog

object_name: acne


subject: UMLS:C2917444

subject_name: Vitamin D Analog [EPC]


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Surgical procedure finding


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: cerebral cavernous malformation


subject: UNII:S3UN2146K9

subject_name: Piromelatine

object_name: insomnia


subject: UNII:S3UN2146K9

object_name: Insomnia, CTCAE 3.0


subject: UNII:S3UN2146K9

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C4547923


subject: UMLS:C4547923


subject: UMLS:C4547923


subject: UMLS:C1533712

subject_name: Heparanase inhibitor PI-88

object_name: lung cancer


subject: UMLS:C1533712

object_name: lung neoplasm


subject: UMLS:C1533712

object_name: lung carcinoma


subject: CHEBI:18248

subject_name: Iron

object_name: acute kidney failure


subject: CHEBI:18248

object_name: Acute Kidney Injury, CTCAE


subject: UNII:KM31LBX59H

subject_name: Florbenazine F-18

object_name: type 1 diabetes mellitus


subject: UMLS:C2934037


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:135918

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:06P3KLK2J8

subject_name: Glofitamab


subject: UNII:06P3KLK2J8


subject: UMLS:C4725069

subject_name: glofitamab


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:135918


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:2965

object_name: Myocardial Reperfusion Injury


subject: UMLS:C0379142


subject: UMLS:C1699394

subject_name: Hylenex

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1699394

object_name: clear cell renal carcinoma


subject: UMLS:C5555467

subject_name: Latozinemab

object_name: Adverse Event Associated with the Nervous System


subject: UMLS:C5705654


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline

object_name: ameloblastoma


subject: CHEBI:33380

subject_name: thulium atom

object_name: Exposure to Hepatitis B virus


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Riley-Day syndrome


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Vomiting, Postoperative


subject: CHEBI:42797

object_name: Postoperative Nausea


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Global Relapse in Viscera


subject: PUBCHEM.COMPOUND:131769963

object_name: Global Relapse in Lymph Nodes


subject: PUBCHEM.COMPOUND:131769963

object_name: Relapse Following Intervention for Kawasaki Disease


subject: PUBCHEM.COMPOUND:131769963

object_name: Global Relapse


subject: PUBCHEM.COMPOUND:131769963

object_name: Global Relapse in Skin


subject: PUBCHEM.COMPOUND:131769963

object_name: Global Relapse in Blood


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: deafness


subject: CHEBI:39548

object_name: hearing loss by exam


subject: CHEBI:39548

object_name: Neck Carcinoma


subject: CHEBI:39548

object_name: head and neck neoplasm


subject: CHEBI:39548

object_name: head and neck cancer


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: spinal cord injury


subject: UMLS:C0000392

subject_name: beta-alanine


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:D000086663

object_name: plasma cell myeloma


subject: MESH:D000086663

object_name: leukemia


subject: MESH:D000086663

object_name: childhood leukemia


subject: MESH:D000086663

object_name: adult lymphoma


subject: MESH:D000086663

object_name: lymphoma


subject: MESH:D000086663

object_name: pediatric lymphoma


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5447311

subject_name: COH04S1 COVID-19 vaccine


subject: UMLS:C5447311


subject: UMLS:C5447311


subject: UMLS:C5447311


subject: UMLS:C5447311


subject: UMLS:C5447311


subject: UMLS:C5447311


subject: UMLS:C2348115

subject_name: SN-38-Loaded Polymeric Micelles NK012

object_name: cancer


subject: UMLS:C2348115

object_name: neoplasm


subject: UMLS:C0556082

subject_name: Amino acid supplement

object_name: rheumatoid arthritis


subject: UMLS:C0556082

object_name: Muscle Atrophy


subject: CHEBI:2549

subject_name: Albuterol

object_name: interstitial lung disease 1


subject: CHEBI:2549

object_name: interstitial lung disease 2


subject: UNII:53PC6LO35W

subject_name: Radezolid

object_name: staphylococcal infection


subject: UNII:53PC6LO35W

object_name: Staphylococcal Skin Infections


subject: UNII:53PC6LO35W

object_name: streptococcal infection


subject: UNII:53PC6LO35W

object_name: skin disorder caused by infection


subject: UNII:53PC6LO35W

object_name: skin infection


subject: UNII:53PC6LO35W

object_name: skin disease caused by bacterial infection


subject: UNII:53PC6LO35W

object_name: cellulitis


subject: UNII:53PC6LO35W

object_name: abscess


subject: UMLS:C4725071

object_name: myelofibrosis


subject: CHEBI:125628

subject_name: Alisertib

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:125628

object_name: Adult Burkitt Lymphoma


subject: CHEBI:125628

object_name: follicular lymphoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: venous thromboembolism


subject: CHEBI:201431

object_name: thrombophilia due to thrombin defect


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: chronic endometritis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:85260

subject_name: spiramycin

object_name: toxoplasmosis


subject: PUBCHEM.COMPOUND:5266

subject_name: Formacidine


subject: KEGG.COMPOUND:C01754

subject_name: Spiramycin


subject: CHEBI:9328

subject_name: Sulfadiazine


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Impaired fasting glucose


subject: UMLS:C0021735

subject_name: Viraferon

object_name: Melanoma of Unknown Primary


subject: UMLS:C5707633

subject_name: Lead Pb 203-VMT01

object_name: metastatic melanoma


subject: UMLS:C5707633

object_name: skin melanoma


subject: UMLS:C5707633

object_name: uveal melanoma


subject: UMLS:C5707633

object_name: mucosal melanoma


subject: UMLS:C5707634

subject_name: Gallium Ga 68-VMT02


subject: UMLS:C5707634


subject: UMLS:C5707634


subject: UMLS:C5707634


subject: CHEBI:83766

subject_name: Olaparib

object_name: ovarian epithelial tumor


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:229233

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:229233

object_name: mycosis fungoides


subject: CHEBI:229233

object_name: Sezary syndrome


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Metastatic Colorectal Adenocarcinoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:45409

subject_name: Ritonavir

object_name: Neoplasm Metastasis


subject: CHEBI:2549

subject_name: Albuterol

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:23359

subject_name: colchicine

object_name: metabolic disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: cold agglutinin disease


subject: CHEBI:9168

object_name: coronary artery disorder


subject: CHEBI:9168

object_name: congenital alveolar dysplasia


subject: CHEBI:9168

object_name: autoimmune hemolytic anemia, cold type


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: Carcinoma liver resectable


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Graft Rejection


subject: CHEBI:50858

subject_name: corticosteroid


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: pleomorphic liposarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Uveitis related cystoid macular edema


subject: UNII:ZL1R02VT79

object_name: steroid-induced glaucoma - borderline


subject: PUBCHEM.COMPOUND:73049652

subject_name: Gadofosveset Trisodium

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:73049652

object_name: ovarian neoplasm


subject: UNII:9430ZR8ZAN

subject_name: gadofosveset


subject: UNII:9430ZR8ZAN


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: Myelodysplasia


subject: UMLS:C0281549

subject_name: Zenapax


subject: CHEBI:58779

object_name: brain injury


subject: CHEBI:49086


subject: CHEBI:16436

subject_name: Citicoline


subject: UMLS:C1522537

subject_name: Recombinant Interferon

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C1522537

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C0876102

subject_name: Nabi-HB

object_name: chronic hepatitis B virus infection


subject: CHEBI:63918

subject_name: Artesunate

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: hypoglycemia


subject: PUBCHEM.COMPOUND:46783403

object_name: dumping syndrome


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A


subject: PUBCHEM.COMPOUND:16129681


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: UMLS:C5706553

subject_name: Anti-HER2 Antibody-drug Conjugate BL-M07D1

object_name: HER2 low breast cancer


subject: UMLS:C2745673

subject_name: huachansu

object_name: esophageal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: Duchenne muscular dystrophy


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Bupivacaine adverse reaction


subject: UNII:LGW2VY8NTG

subject_name: DELPACIBART ZOTADIRSEN

object_name: atrophic muscular disease


subject: UNII:LGW2VY8NTG


subject: UNII:LGW2VY8NTG

object_name: X-linked disease


subject: UNII:LGW2VY8NTG

object_name: musculoskeletal system disorder


subject: UNII:LGW2VY8NTG

object_name: nervous system disorder


subject: UNII:LGW2VY8NTG

object_name: genetic disease


subject: UNII:LGW2VY8NTG

object_name: neuromuscular disease


subject: UNII:LGW2VY8NTG

object_name: muscular dystrophy


subject: UNII:LGW2VY8NTG

object_name: myopathy


subject: UNII:LGW2VY8NTG

object_name: muscle tissue disorder


subject: UMLS:C0906802

object_name: prostate disorder


subject: UMLS:C0906802

object_name: prostate cancer


subject: UMLS:C0906802

object_name: prostate neoplasm


subject: UMLS:C0906802

object_name: male reproductive system neoplasm


subject: UMLS:C0906802

object_name: male reproductive organ cancer


subject: UMLS:C0906802

object_name: male reproductive system disorder


subject: UMLS:C0906802

object_name: Neoplasm of the genitourinary tract


subject: UMLS:C0906802

object_name: Abdominal Neoplasms


subject: MESH:C000728461

object_name: Sicca Syndrome


subject: MESH:C000728461

object_name: Primary Sjögren's syndrome


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: Distress


subject: CHEBI:18332

object_name: Emotional Distress


subject: CHEBI:18332

object_name: anxiety


subject: CHEBI:18332

object_name: anxiety disorder


subject: CHEBI:18332

object_name: Anxiety symptoms


subject: CHEBI:18332

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:18332

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C0079691

subject_name: Levothroid

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C0079691

object_name: Fatigue


subject: UMLS:C0079691


subject: UMLS:C0079691


subject: UMLS:C0079691

object_name: thyroid tumor


subject: UMLS:C0079691

object_name: thyroid gland carcinoma


subject: UMLS:C0079691

object_name: thyroid cancer


subject: UMLS:C0079691

object_name: Depressed mood


subject: UMLS:C0079691

object_name: Cancer patients and suicide and depression


subject: UMLS:C0079691

object_name: Depressed - symptom


subject: UMLS:C0079691

object_name: Depression, CTCAE


subject: UMLS:C0079691


subject: UMLS:C0079691


subject: UMLS:C0079691


subject: UMLS:C0079691


subject: UMLS:C0079691


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: HIV infection


subject: UNII:Y2T4ALDEAT

object_name: Myelodysplasia


subject: UNII:Y2T4ALDEAT

object_name: Adult Myelodysplastic Syndrome


subject: UNII:Y2T4ALDEAT

object_name: childhood myelodysplastic syndrome


subject: UNII:Y2T4ALDEAT

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: Moderate albuminuria


subject: UNII:T74V9O0Y2W

object_name: atopic eczema


subject: UMLS:C5691165

subject_name: Auxora

object_name: acute kidney failure


subject: UMLS:C5691165

object_name: Acute Kidney Injury, CTCAE


subject: GTOPDB:11097

subject_name: efineptakin alfa

object_name: Recurrent Glioblastoma, IDH-Wildtype


subject: GTOPDB:11097

object_name: Recurrent Childhood Gliosarcoma


subject: GTOPDB:11097

object_name: Recurrent Gliosarcoma


subject: GTOPDB:11097

object_name: high grade astrocytic tumor


subject: CHEMBL.COMPOUND:CHEMBL4594590

subject_name: EFINEPTAKIN ALFA


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Ehlers-Danlos syndrome, vascular type


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IIIA Lung Large Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Adenocarcinoma of lung stage IIIA


subject: PUBCHEM.COMPOUND:2767

object_name: Large cell lung cancer stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Lung Large Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Adenocarcinoma of lung, stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Adenocarcinoma of lung stage IIIB


subject: PUBCHEM.COMPOUND:2767

object_name: Large cell lung cancer stage IV


subject: CHEBI:192842

subject_name: Methoxyamine

object_name: Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:192842

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:192842

object_name: Non-small cell lung cancer stage III


subject: CHEBI:192842

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:192842

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842


subject: CHEBI:192842

object_name: Adenocarcinoma of lung, stage IV


subject: UNII:203546OLMF

subject_name: METHOXYAMINE HYDROCHLORIDE


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UNII:203546OLMF


subject: UMLS:C0951345

subject_name: methoxyamine hydrochloride


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: UMLS:C0951345


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:3082

subject_name: Betaxolol

object_name: ocular hypertension


subject: CHEBI:3082

object_name: Ocular hypertension


subject: CHEBI:3082

object_name: glaucoma


subject: CHEBI:3082

object_name: Glaucoma, CTCAE


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: Congenital postural scoliosis


subject: UNII:YZS3R7LP44

object_name: scoliosis


subject: UNII:YZS3R7LP44

object_name: Scoliosis, CTCAE


subject: RXCUI:1043617

subject_name: eucalyptol / menthol / methyl salicylate / thymol Mouthwash

object_name: gonorrhea


subject: UNII:V9KGF25853

object_name: Alzheimer disease


subject: CHEBI:51032

subject_name: Epinastine

object_name: perennial allergic rhinitis


subject: CHEBI:51209

subject_name: Pseudoephedrine


subject: UMLS:C3489514

object_name: prostate cancer


subject: UMLS:C3489514

object_name: prostate neoplasm


subject: UNII:D01E4B1U35

subject_name: Poseltinib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:151315

subject_name: Heparin

object_name: Blood Loss


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70746

object_name: osteoarthritis, hip


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: focal segmental glomerulosclerosis


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:191174

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Transformed Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: B-cell lymphoma stage II


subject: CHEBI:4026

object_name: B-cell lymphoma stage IV


subject: CHEBI:4026

object_name: B-cell lymphoma stage III


subject: CHEBI:4026

object_name: mediastinal gray zone lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: CHEBI:231614

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:231683

subject_name: Anakinra

object_name: pneumonia


subject: CHEBI:231683

object_name: COVID-19-Associated Pneumonia


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: UMLS:C2697511

object_name: Severe Sepsis


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Chronic kidney disease requiring chronic dialysis


subject: DRUGBANK:DB14101

object_name: kidney failure


subject: DRUGBANK:DB14101

object_name: Renal Failure, CTCAE


subject: UMLS:C0677666

subject_name: soy protein isolate


subject: UMLS:C0677666


subject: UMLS:C0677666


subject: UNII:UM4TJY3PCY

object_name: circadian rhythm sleep disorder


subject: UMLS:C0879422

subject_name: B43-Genistein Immunoconjugate

object_name: leukemia


subject: UMLS:C0879422

object_name: childhood leukemia


subject: UMLS:C0879422

object_name: adult lymphoma


subject: UMLS:C0879422

object_name: lymphoma


subject: UMLS:C0879422

object_name: pediatric lymphoma


subject: GTOPDB:10492

subject_name: envafolimab

object_name: biliary tract neoplasm


subject: UNII:ES1M06M6QH


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: Impacted third molar tooth


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: benign prostatic hyperplasia


subject: CHEBI:91512

object_name: Blast Phase


subject: CHEBI:91512

object_name: Blastic Phase


subject: CHEBI:91512

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: CHEBI:71019


subject: UMLS:C4053602

subject_name: Anti-IL-4/IL-13 Combination Agent QBX258

object_name: asthma


subject: CHEBI:412516

object_name: Hypoxemia


subject: CHEBI:412516

object_name: Hypoxia, CTCAE


subject: UMLS:C3886589


subject: UMLS:C3886589


subject: UNII:KE3U2023NP

subject_name: Poractant alfa

object_name: Infant, Premature, Diseases


subject: UMLS:C1541521

subject_name: AMG 386

object_name: peritoneum cancer


subject: CHEBI:144094

subject_name: bicalutamide

object_name: metabolic disease


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastasis


subject: UNII:KXG2PJ551I

object_name: Metastatic Lesion


subject: UNII:KXG2PJ551I

object_name: HER2 gene amplification


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:UMD07X179E

subject_name: CERTOLIZUMAB

object_name: cardiovascular disorder


subject: UMLS:C1172157


subject: CHEBI:151315

subject_name: Heparin

object_name: lower urinary tract symptom


subject: CHEBI:151315

object_name: Postoperative urinary tract infection


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: CHEBI:3640

subject_name: Chlorothiazide

object_name: nephrogenic diabetes insipidus


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:32188

subject_name: Tegafur

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:32188

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:90227

subject_name: Selumetinib

object_name: low grade serous adenocarcinoma of ovary


subject: CHEBI:90227

object_name: micropapillary serous carcinoma


subject: CHEBI:90227

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:90227

object_name: borderline ovarian serous tumor


subject: CHEBI:90227

object_name: primary peritoneal carcinoma


subject: CHEBI:90227

object_name: peritoneal carcinoma


subject: CHEBI:90227

object_name: Primary Peritoneal Low Grade Serous Adenocarcinoma


subject: CHEBI:90227

object_name: Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:ZNC37E4KAK

subject_name: ELRITERCEPT

object_name: Cytopenia


subject: UMLS:C5417971

subject_name: Elritercept


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Endometrial neoplasm malignant metastatic


subject: UMLS:C3646552

subject_name: progestins norethindrone

object_name: Taylor syndrome


subject: UMLS:C2343216

subject_name: maca root

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:3367

object_name: Malignant melanoma stage IV


subject: CHEBI:63599

subject_name: Fludarabine


subject: GTOPDB:4985


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PR:000001151

subject_name: Toll-like receptor 1


subject: DRUGBANK:DB18130

object_name: Duchenne muscular dystrophy


subject: PUBCHEM.COMPOUND:3222

object_name: hyperhomocysteinemia


subject: CHEBI:4784

subject_name: Enalapril


subject: UMLS:C0600128

subject_name: Renitec


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: stroke disorder


subject: CHEBI:231673

object_name: cerebrovascular disorder


subject: CHEBI:231673

object_name: Stroke (heart beat)


subject: CHEBI:231673

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: UNII:EGC16R10V0

subject_name: DALANTERCEPT

object_name: endometrium adenocarcinoma


subject: UNII:EGC16R10V0

object_name: endometrial squamous cell carcinoma


subject: UNII:EGC16R10V0

object_name: squamous cell carcinoma of the corpus uteri


subject: UNII:EGC16R10V0

object_name: endometrial serous adenocarcinoma


subject: UNII:EGC16R10V0

object_name: endometrial mixed adenocarcinoma


subject: UNII:EGC16R10V0

object_name: endometrial mucinous adenocarcinoma


subject: UNII:EGC16R10V0

object_name: endometrial clear cell adenocarcinoma


subject: UNII:EGC16R10V0

object_name: endometrial transitional cell carcinoma


subject: UNII:EGC16R10V0

object_name: transitional cell carcinoma of the corpus uteri


subject: UNII:EGC16R10V0

object_name: endometrial undifferentiated carcinoma


subject: UNII:EGC16R10V0

object_name: undifferentiated carcinoma of the corpus uteri


subject: UMLS:C2981815

subject_name: Dalantercept


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C2981815


subject: UMLS:C5543809


subject: CHEBI:6030

subject_name: Isoniazid

object_name: alcohol abuse


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306

object_name: AIDS


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: esthesioneuroblastoma


subject: GTOPDB:11376

object_name: olfactory neuroblastoma


subject: GTOPDB:11376

object_name: nasal cavity neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: systemic mastocytosis


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Corneal pannus


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:60751

subject_name: Temoporfin

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:60751

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:60751

object_name: head and neck cancer


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:9437


subject: CHEBI:5938

subject_name: Interferon beta-1b

object_name: chronic progressive multiple sclerosis


subject: UMLS:C2020633

subject_name: streptokinase injection

object_name: Acute pulmonary embolism


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: UMLS:C4329347

subject_name: CD95-Fc Fusion Protein CAN008

object_name: glioblastoma


subject: UMLS:C4329347

object_name: Brain Stem Glioblastoma


subject: UMLS:C4329347

object_name: glioma susceptibility 1


subject: UNII:VC1D38AGN9

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:VC1D38AGN9

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C3641005


subject: UMLS:C3641005


subject: UMLS:C1881500

subject_name: Azixa


subject: UMLS:C1881500


subject: UMLS:C1881500


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Colon perforation


subject: CHEBI:73604

object_name: Colon Neoplasm


subject: CHEBI:73604

object_name: benign colon neoplasm


subject: CHEBI:73604

object_name: intestinal perforation


subject: CHEBI:73604

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: complications; vaccination, reaction, serum


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: CHEBI:48299

subject_name: Erythritol

object_name: type 2 diabetes mellitus


subject: CHEBI:45783

subject_name: Imatinib

object_name: endometrial cancer


subject: CHEBI:45783

object_name: uterine corpus cancer


subject: CHEBI:45783

object_name: endometrial carcinoma


subject: CHEBI:45783

object_name: small intestine cancer


subject: CHEBI:45783

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:9800288

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:9800288

object_name: cirrhotic cardiomyopathy


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:PVI5M0M1GW

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:PVI5M0M1GW

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:PVI5M0M1GW

object_name: Chronic lymphocytic leukaemia stage 3


subject: UNII:PVI5M0M1GW

object_name: Chronic lymphocytic leukaemia stage 4


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:125354

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:125354

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:125354

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:125354

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:125354

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:125354

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:125354

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:125354

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:125354

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:125354

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:125354

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:125354


subject: CHEBI:125354

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:125354

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:125354

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:125354

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:125354

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:125354

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:125354

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:125354

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:125354

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:125354

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:125354

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:125354

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:125354

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:125354

object_name: Blast Phase


subject: CHEBI:125354

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:125354

object_name: Mantle cell lymphoma stage III


subject: CHEBI:125354

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:125354

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:125354

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:125354

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:125354

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:125354

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:125354

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:125354

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:125354

object_name: Marginal zone lymphoma stage III


subject: CHEBI:125354

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:125354

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:125354

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:125354

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:125354

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:125354

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:125354

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:125354

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:125354

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:125354

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C1144709

subject_name: Natriuretic Peptides

object_name: heart failure


subject: UMLS:C1144709

object_name: congestive heart failure


subject: UMLS:C1144709

object_name: cardiomyopathy


subject: UMLS:C2709270

subject_name: Natriuretic peptide


subject: UMLS:C2709270


subject: UMLS:C2709270


subject: UMLS:C3537020

subject_name: Natriuretic Peptide [EPC]


subject: UMLS:C3537020


subject: UMLS:C3537020


subject: PR:000001948

subject_name: tumor necrosis factor ligand superfamily member 13B

object_name: IgA Deficiency


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: cervical polyp


subject: CHEBI:85164


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Tabagism


subject: CHEBI:39585

subject_name: Carbidopa

object_name: nicotine dependence


subject: CHEBI:39585


subject: UMLS:C5139959

object_name: obstructive sleep apnea syndrome


subject: UNII:LMQ24G57E9

subject_name: Daridorexant


subject: CHEBI:86285

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:86285

object_name: obesity


subject: CHEBI:86285

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:91400

subject_name: Afatinib

object_name: benign urinary system neoplasm


subject: CHEBI:91400

object_name: urinary system neoplasm


subject: UMLS:C1950497

subject_name: optive

object_name: ocular hypertension


subject: UMLS:C1950497

object_name: Ocular hypertension


subject: UMLS:C1950497

object_name: open-angle glaucoma


subject: UMLS:C4732961

subject_name: bevacizumab biosimilar MB02

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UMLS:C4732961

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C4732961

object_name: metastatic colorectal cancer


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Chronic iron overload


subject: UMLS:C1707141

object_name: melanoma


subject: UMLS:C1707141

object_name: Neoplasm Metastasis


subject: UMLS:C1707142

subject_name: ELACYT


subject: UMLS:C1707142


subject: CHEBI:28445

subject_name: vincristine

object_name: Wilms tumor 1


subject: CHEBI:141447

subject_name: Trp-Asn

object_name: West Nile viral infection


subject: UMLS:C5666951

subject_name: PCNA Inhibitor AOH1996

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C5666951

object_name: non-small cell lung carcinoma


subject: UMLS:C5666951

object_name: synovial sarcoma


subject: UMLS:C5666951

object_name: pancreatic neoplasm


subject: UMLS:C5666951

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5666951

object_name: malignant pancreatic neoplasm


subject: UMLS:C5666951

object_name: leiomyosarcoma


subject: UMLS:C5666951

object_name: ovarian cancer


subject: UMLS:C5666951

object_name: ovarian neoplasm


subject: UMLS:C5666951

object_name: ovarian carcinoma


subject: UMLS:C5666951

object_name: pediatric osteosarcoma


subject: UMLS:C5666951

object_name: Osteosarcoma


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: Asthmatic Airway Remodeling


subject: UMLS:C3640968

subject_name: Anti-TGF-beta RII Monoclonal Antibody IMC-TR1

object_name: neoplasm


subject: UMLS:C3640968

object_name: Tumor Mass


subject: MESH:C000594566

object_name: gastric ulcer


subject: MESH:C000594566

object_name: Gastric Ulcer, CTCAE


subject: MESH:C000594566

object_name: gastritis


subject: MESH:C000594566

object_name: Gastritis, CTCAE


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Pruritus


subject: UMLS:C1097925

object_name: Clostridium difficile diarrhea


subject: UMLS:C1097925

object_name: Antibiotic-associated diarrhea


subject: UMLS:C1097925

object_name: Clostridium difficile colitis


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: amyotrophic lateral sclerosis


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: Solid Neoplasm


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: CHEBI:7627

subject_name: Norethisterone


subject: PR:000022848

subject_name: guanosine-inosine kinase

object_name: avian influenza


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: CHEBI:9449

subject_name: Terbutaline

object_name: Labor Pain


subject: CHEBI:73614

subject_name: Met-Thr

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:33361

subject_name: meitnerium atom


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: Atopic rhinitis


subject: UNII:C137DTR5RG

object_name: Allergic Rhinitis, CTCAE


subject: UNII:C137DTR5RG

object_name: Rhinosinusitis


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: myocardial infarction


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: lung cancer


subject: CHEBI:89324

object_name: lung neoplasm


subject: CHEBI:89324

object_name: lung carcinoma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: ulcerative colitis


subject: CHEBI:51254

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: UMLS:C4764260

subject_name: PI3K-delta Inhibitor YY-20394

object_name: mantle cell lymphoma


subject: UMLS:C4764260

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C4764260

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4764260

object_name: marginal zone lymphoma


subject: UMLS:C4764260

object_name: MALT lymphoma


subject: UMLS:C0244196

subject_name: Kliogest

object_name: osteoporosis


subject: UMLS:C0244196

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0244196

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0244196

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C1541521

subject_name: AMG 386

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C5690426

object_name: kidney failure


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: cognitive disorder


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: B-cell non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: B-cell neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: follicular lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: Indolent Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: Indolent lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL4594500

object_name: B cells--Tumors


subject: UMLS:C4688623


subject: UMLS:C4688623


subject: UMLS:C4688623


subject: UMLS:C4688623


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents

object_name: Shock


subject: UMLS:C0042397

object_name: hypotension


subject: UMLS:C0042397

object_name: Hypotension, CTCAE


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:84036

subject_name: Aldoxorubicin

object_name: Small cell lung cancer metastatic


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Toxicity due to chemotherapy


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:4672

subject_name: Docetaxel


subject: MESH:C079198

subject_name: S 1 (combination)


subject: CHEBI:94366

subject_name: itraconazole

object_name: opiate dependence


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: Papulopustular Rosacea


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Primary malignant neoplasm


subject: CHEBI:78543

object_name: cancer


subject: CHEBI:78543

object_name: childhood malignant neoplasm


subject: CHEBI:78543

object_name: Malignant obstetric neoplasm


subject: GTOPDB:12907

subject_name: bexmarilimab

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594544

subject_name: BEXMARILIMAB


subject: UMLS:C5204510


subject: UMLS:C3257517

subject_name: apple extract

object_name: Prediabetes


subject: UMLS:C3257517

object_name: type 2 diabetes mellitus


subject: UMLS:C3257517

object_name: Diabetes


subject: UMLS:C3257517

object_name: diabetes mellitus


subject: DRUGBANK:DB10501

subject_name: Apple


subject: DRUGBANK:DB10501


subject: DRUGBANK:DB10501


subject: DRUGBANK:DB10501


subject: DRUGBANK:DB10501

object_name: cardiovascular disorder


subject: CHEBI:31705

subject_name: Iodixanol

object_name: kidney failure


subject: UMLS:C5222450

subject_name: Insulin Aspart Injection


subject: UMLS:C5222450


subject: UMLS:C5222450


subject: UMLS:C5237038

subject_name: PI3K-delta Inhibitor SHC014748M

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:39462

subject_name: pilocarpine

object_name: OPTN-related open angle glaucoma


subject: CHEBI:39462

object_name: Ocular hypertension


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:8207


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Maternity blues


subject: PR:000010844

subject_name: E3 ubiquitin-protein ligase MYLIP

object_name: opioid use


subject: PR:000010844


subject: PR:000010459

subject_name: MLX-interacting protein


subject: PR:000010459


subject: PR:000010182

subject_name: E3 ubiquitin-protein ligase MARCHF8


subject: PR:000010182


subject: CHEBI:190523

subject_name: fructooligosaccharide

object_name: chronic kidney disease


subject: CHEBI:190523

object_name: Chronic Kidney Disease, CTCAE


subject: MESH:C116580


subject: MESH:C116580


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: conjunctivitis


subject: UNII:420K487FSG

object_name: Conjunctivitis, CTCAE


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Stress


subject: CHEBI:8228

object_name: alcohol-related disorders


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Prehypertension


subject: UMLS:C1313726

object_name: glioblastoma


subject: UMLS:C1313726

object_name: Childhood Glioblastoma


subject: UMLS:C1313726

object_name: adult glioblastoma


subject: UMLS:C1313726

object_name: Brain Stem Glioblastoma


subject: UMLS:C1313726

object_name: glioma susceptibility 1


subject: GTOPDB:10140

subject_name: spartalizumab

object_name: metastatic colorectal cancer


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053576

subject_name: Immunotherapeutic Combination Product CMB305

object_name: adult liposarcoma


subject: UMLS:C4053576

object_name: liposarcoma


subject: UMLS:C4053576

object_name: pediatric liposarcoma


subject: UMLS:C4053576

object_name: myxoid liposarcoma


subject: UMLS:C4053576

object_name: myxoid/round cell liposarcoma


subject: UMLS:C4053576

object_name: Metastatic sarcoma


subject: UMLS:C4053576

object_name: Locally Advanced Sarcoma


subject: UMLS:C4053576

object_name: Childhood Synovial Sarcoma


subject: UMLS:C4053576

object_name: Adult Synovial Sarcoma


subject: UMLS:C4053576

object_name: synovial sarcoma


subject: UMLS:C4053576

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Glue ear


subject: UMLS:C3540708

object_name: serous otitis media


subject: UMLS:C3540708

object_name: Otitis media with effusion


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:37956

subject_name: histamine antagonist


subject: CHEBI:37956


subject: CHEBI:37956


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0740098


subject: UMLS:C0740098


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C0019592


subject: UMLS:C0019592


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: UMLS:C3536809


subject: UMLS:C3536809


subject: CHEBI:94559

subject_name: Levocetirizine


subject: CHEBI:94559


subject: CHEBI:94559


subject: UMLS:C0042398

subject_name: Nasal Decongestants


subject: UMLS:C0042398


subject: UMLS:C0042398


subject: UMLS:C0260264

subject_name: steroid drugs


subject: UMLS:C0260264


subject: UMLS:C0260264


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: hepatitis C


subject: UNII:21K6M2I7AG

object_name: chronic hepatitis C virus infection


subject: CHEBI:3223

subject_name: Buspirone

object_name: Dyskinesia


subject: CHEBI:3223

object_name: movement disorder


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:118981713

subject_name: onfasprodil

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:118981713

object_name: major depressive disorder


subject: CHEBI:36791

subject_name: Escitalopram

object_name: cancer


subject: CHEBI:3723

subject_name: Citalopram


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: biopsy characteristics


subject: CHEBI:42797

subject_name: Gabapentin

object_name: complex partial epilepsy


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: primary ovarian failure


subject: CHEBI:4903

object_name: premature menopause


subject: CHEBI:7627

subject_name: Norethisterone


subject: CHEBI:7627


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: bone cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816

object_name: kidney neoplasm


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEMBL.COMPOUND:CHEMBL1743064

subject_name: ROBATUMUMAB

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743064


subject: CHEMBL.COMPOUND:CHEMBL1743064


subject: CHEMBL.COMPOUND:CHEMBL1743064

object_name: Childhood Neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL1743064

object_name: neuroblastoma


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C3467798


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C0699595

subject_name: Septra

object_name: hypospadias


subject: UMLS:C0699595

object_name: Penile hypospadias


subject: UMLS:C1142717

object_name: kidney disorder


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: filariasis


subject: CHEBI:35812

object_name: Infection by Filaroides


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: exanthem


subject: PUBCHEM.COMPOUND:17753757

object_name: Eruptions


subject: UMLS:C5706375

subject_name: Anti-LAIR1 Monoclonal Antibody NGM438

object_name: colorectal cancer


subject: UMLS:C5706375

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4745031

subject_name: MCL-1 inhibitor AMG 397

object_name: acute myeloid leukemia


subject: UMLS:C4745031

object_name: Myelodysplasia


subject: UMLS:C4745031

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C4745031

object_name: myoclonic dystonia 11


subject: UMLS:C4745031

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4745031

object_name: non-Hodgkin lymphoma


subject: UMLS:C4745031

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C4745031

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4745031

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4745031

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4745031

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4745031

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C3475162

subject_name: phentermine / topiramate

object_name: Weight loss


subject: UMLS:C3475162

object_name: Weight Loss, CTCAE


subject: UMLS:C3475162

object_name: bipolar I disorder


subject: UMLS:C3475162

object_name: schizoaffective disorder


subject: UMLS:C3475162

object_name: bipolar II disorder


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:7465


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:167574

subject_name: Semaglutide


subject: CHEBI:167574


subject: CHEBI:167574


subject: CHEBI:94708

subject_name: Diacerein

object_name: Primary gout


subject: UMLS:C4727285

object_name: Solid Neoplasm


subject: UMLS:C4727285

object_name: neoplasm


subject: UMLS:C4527193

object_name: colorectal cancer


subject: UMLS:C4527193

object_name: colorectal carcinoma


subject: UMLS:C4527193

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4594495


subject: CHEMBL.COMPOUND:CHEMBL4594495


subject: CHEMBL.COMPOUND:CHEMBL4594495


subject: UMLS:C4526974

subject_name: Anti-RNF43 Antibody-drug Conjugate SC-006


subject: UMLS:C4526974


subject: UMLS:C4526974


subject: MESH:C089950

subject_name: MF59 oil emulsion


subject: GTOPDB:11827

subject_name: telitacicept

object_name: systemic sclerosis


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: CHEBI:30742

subject_name: macrogol

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:30742

object_name: acute-on-chronic liver failure


subject: CHEBI:57586

subject_name: biotinate

object_name: chronic progressive multiple sclerosis


subject: CHEBI:15956

subject_name: Biotin


subject: PUBCHEM.COMPOUND:91932423

subject_name: Diquas

object_name: dry eye syndrome


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: thyroid gland papillary carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Childhood Liver Cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Kidney Wilms Tumor


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:139072

object_name: Cannabis use disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Advanced cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: cardiomyopathy


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: leiomyoma


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: CHEBI:91398

object_name: malignant pleural mesothelioma


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: rickets


subject: CHEBI:22652

object_name: Nutritional Rickets


subject: CHEBI:22652

object_name: Bone turnover rate disorder


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: Hemorrhage


subject: CHEBI:4856

subject_name: Esmolol

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: CHEBI:4856

object_name: Blood Pressure Finding


subject: CHEBI:4856

object_name: Systemic arterial pressure


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: CHEBI:167638


subject: UMLS:C4725098

subject_name: HAAH Lambda phage Vaccine SNS-301

object_name: head and neck squamous cell carcinoma


subject: UMLS:C0453260

subject_name: ginger root

object_name: Myalgia


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: sarcopenia


subject: UMLS:C0733796

subject_name: Gastrografin

object_name: colon carcinoma


subject: UMLS:C0733796

object_name: colorectal cancer


subject: UMLS:C0733796

object_name: colon cancer


subject: UMLS:C0733796

object_name: polyp of colon


subject: UMLS:C0733796

object_name: inflammatory bowel disease


subject: UMLS:C0733796

object_name: Gastrointestinal hemorrhage


subject: UNII:95D580798S

subject_name: Picosulfuric acid


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:135552

subject_name: Prucalopride


subject: CHEBI:135552


subject: CHEBI:135552


subject: CHEBI:135552


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356

object_name: Increased reactive oxygen species production


subject: PUBCHEM.COMPOUND:72680331

subject_name: Gemigliptin

object_name: Diabetes


subject: PUBCHEM.COMPOUND:72680331

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: tuberous sclerosis


subject: PUBCHEM.COMPOUND:521372

object_name: situs inversus


subject: PUBCHEM.COMPOUND:521372

object_name: tuberous sclerosis 1


subject: UMLS:C0003448

subject_name: Antitubercular Agents

object_name: pneumonia


subject: UMLS:C0003448

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0003448

object_name: cytomegalovirus infection


subject: UMLS:C0003448

object_name: AIDS


subject: CHEBI:63635

subject_name: Valganciclovir


subject: CHEBI:63635


subject: CHEBI:63635

object_name: tuberculosis


subject: CHEBI:63635


subject: UNII:YP8G3I74EL

subject_name: Vorolanib

object_name: nonpapillary renal cell carcinoma


subject: UNII:YP8G3I74EL

object_name: clear cell renal carcinoma


subject: UNII:YP8G3I74EL

object_name: renal cell adenocarcinoma


subject: UNII:YP8G3I74EL

object_name: refractory cytopenia of childhood


subject: UNII:YP8G3I74EL

object_name: renal cell carcinoma


subject: UNII:YP8G3I74EL

object_name: renal carcinoma


subject: UNII:YP8G3I74EL

object_name: kidney neoplasm


subject: UNII:YP8G3I74EL

object_name: kidney cancer


subject: GTOPDB:12966

subject_name: cadonilimab


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: GTOPDB:12966


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: fibromyalgia


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: fallopian tube carcinoma


subject: UMLS:C0013227

object_name: fallopian tube cancer


subject: UMLS:C0013227

object_name: malignant epithelial tumor of ovary


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C5666997

subject_name: Anti-CLDN6 Antibody-drug Conjugate TORL-1-23


subject: UMLS:C5666997


subject: UMLS:C5666997


subject: UMLS:C5666997


subject: UMLS:C3864306

subject_name: meningococcal B vaccine, fully recombinant

object_name: meningococcal infection


subject: UMLS:C3864306

object_name: meningococcal meningitis


subject: UMLS:C5783941

subject_name: P2Y12 Inhibitor

object_name: Heart Disease Risk Factors


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: Constipation


subject: CHEBI:51141

object_name: Constipation, CTCAE


subject: UMLS:C5555585

subject_name: ADAM9-targeting Antibody-drug Conjugate IMGC936

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4086994

object_name: thymus cancer


subject: UMLS:C4086994

object_name: Thymoma malignant recurrent


subject: UMLS:C4086994

object_name: thymic epithelial neoplasm


subject: CHEBI:45716

subject_name: Vorinostat

object_name: small cell lung carcinoma


subject: UMLS:C3254570

subject_name: sirukumab

object_name: lupus nephritis


subject: CHEBI:26345

subject_name: prostaglandins I

object_name: melanoma


subject: MESH:D044062

subject_name: Prostaglandins I


subject: CHEBI:4672

subject_name: Docetaxel

object_name: GASTRIC CANCER ADENOCARCINOMA METASTATIC


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: prostate cancer


subject: UNII:4B3SC438HI

object_name: prostate neoplasm


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:93775

subject_name: Amethopterin

object_name: head and neck squamous cell carcinoma


subject: CHEBI:93775

object_name: Recurrence


subject: CHEBI:93775

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:93775

object_name: Recurrent tumor


subject: CHEBI:93775

object_name: Embolism, Tumor


subject: CHEBI:93775

object_name: Metastasis


subject: CHEBI:93775

object_name: Metastatic Lesion


subject: CHEBI:93775

object_name: nasopharyngeal carcinoma


subject: CHEBI:93775

object_name: Niemann-Pick disease type C


subject: CHEBI:93775

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Recurrent disease


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:78384800

subject_name: Taxanes


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: PUBCHEM.COMPOUND:78384800


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C0796419


subject: UMLS:C3541958

subject_name: Taxanes, antineoplastic


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: UMLS:C3541958


subject: CHEBI:7852

subject_name: Oxycodone

object_name: chronic kidney disease


subject: CHEBI:7852

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Behcet disease


subject: CHEBI:201431

object_name: choroiditis


subject: CHEBI:201431

object_name: posterior uveitis


subject: CHEBI:201431

object_name: retinal vasculitis


subject: CHEBI:201431

object_name: panuveitis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:544190

object_name: lung disorder


subject: PUBCHEM.COMPOUND:544190

object_name: History of - respiratory disease


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7798


subject: UNII:FB39E94UXK

object_name: Chronic motor tic disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: AIDS


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: diarrhea


subject: CHEBI:6950

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:6950

object_name: Diarrhea, CTCAE


subject: CHEBI:6950

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:21982135

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:73038

subject_name: Parecoxib


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: acute lymphoblastic leukemia


subject: UMLS:C0305354

subject_name: Attenuvax

object_name: HIV infection


subject: UMLS:C0305354

object_name: measles


subject: UMLS:C0538777

subject_name: ancestim

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C0538777

object_name: aplastic anemia


subject: UMLS:C0538777

object_name: idiopathic aplastic anemia


subject: UMLS:C0538777

object_name: pancytopenia


subject: PUBCHEM.COMPOUND:3367

object_name: myxoid liposarcoma


subject: PUBCHEM.COMPOUND:3367

object_name: myxoid/round cell liposarcoma


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000014196

object_name: Childhood Synovial Sarcoma


subject: PR:000014196

object_name: Adult Synovial Sarcoma


subject: PR:000014196

object_name: synovial sarcoma


subject: PR:000014196

object_name: plasma cell myeloma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: retinoblastoma


subject: CHEBI:49900

object_name: childhood germ cell tumor


subject: CHEBI:49900

object_name: ovarian cancer


subject: CHEBI:49900

object_name: ovarian neoplasm


subject: CHEBI:49900

object_name: ovarian carcinoma


subject: CHEBI:49900

object_name: malignant soft tissue neoplasm


subject: CHEBI:49900

object_name: sarcoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:151315

subject_name: Heparin

object_name: non-small cell lung carcinoma


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: RXCUI:236782

subject_name: Saccharomyces boulardii Oral Capsule

object_name: Recurrent urinary tract infections


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: colorectal carcinoma


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UNII:V5PC588N7G

subject_name: Mag 2 (TN)

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEBI:16010


subject: PUBCHEM.COMPOUND:165412126

object_name: cancer


subject: PUBCHEM.COMPOUND:165412126

object_name: nervous system cancer


subject: UNII:NG4RSF722G


subject: UNII:NG4RSF722G


subject: UMLS:C0242974

subject_name: GABA Agonists

object_name: cocaine abuse


subject: CHEBI:6923

subject_name: Miconazole

object_name: Melasma


subject: CHEBI:16134

subject_name: Ammonia

object_name: cardiomyopathy


subject: UMLS:C5447533

subject_name: Fluorine F 18 3F-PHPG


subject: UMLS:C3711128


subject: PUBCHEM.COMPOUND:132451761

subject_name: Forteo

object_name: osteogenesis imperfecta


subject: UMLS:C0376564


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Advanced Follicular Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872